Últimos ensayos

EudraCT Number: 2004-000231-29

Sponsor Protocol Number: WV16726

Start Date: 2004-08-12

Sponsor Name: Roche Products Ltd

Full Title: Safety and pharmacokinetics of valganciclovir syrup formulation in paediatric solid organ transplant recipients

Medical condition: solid organ transplants

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: ES (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000843-61

Sponsor Protocol Number: 7148LBMC02

Start Date: 2004-08-12

Sponsor Name: ZAMBON GROUP

Full Title: Efficacy and tolerability of topical Ketoprofen TDS patch KEOFIX in the treatment of traumatic painful soft-tissue injuries

Medical condition: ANKLE SPRAIN

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10023229		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-001325-14

Sponsor Protocol Number: 580299/008

Start Date: 2004-08-12

Sponsor Name: GlaxoSmithKline SA

Full Title: Estudio en fase III, doble ciego, aleatorizado, controlado, multicéntrico para evaluar la eficacia de la vacuna HPV-16/18 VLP/AS04 de GlaxoSmithKline Biologicals comparada con la vacuna antihepatit...

Medical condition: cervical cancer => study is conducted in healthy female

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Female

Trial protocol: ES (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000240-25

Sponsor Protocol Number: CSPP100A2204

Start Date: 2004-08-12

Sponsor Name: Novartis Sverige AB

Full Title: An 8 week double-blind, multicenter, randomized, multifactorial, placebo-controlled, parallel-group study to evaluate the efficacy and safety of aliskiren administered alone and in combination with...

Medical condition: Treatment of essential hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) FI (Completed) SK (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-000138-35

Sponsor Protocol Number: 20030216

Start Date: 2004-08-12

Sponsor Name: Amgen Inc

Full Title: A Study to Evaluate AMG 162 in the Treatment of Postmenopausal Osteoporosis FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis every & Months)

Medical condition: Treatment of postmenopausal osteoporosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: SE (Completed) FI (Completed) LV (Completed) NO (Completed) SK (Completed) ES (Completed) AT (Completed) LT (Completed) CZ (Completed) HU (Completed) GB (Completed) DK (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-001369-17

Sponsor Protocol Number: CFEM345D2406

Start Date: 2004-08-12

Sponsor Name: Novartis Farmacéutica S.A.

Full Title: An open-label, randomized, multicenter study to evaluate the use of Zoledronic Acid in the prevention of cancer treatment-related bone loss in postmenopausal women with ER+ and/or PgR+ breast cance...

Medical condition: Prevention of cancer treatment-related bone loss in postmenopausal women with ER+ and/or PgR+ breast cancer receiving Letrozole as adjuvant therapy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-000326-70

Sponsor Protocol Number: R076477-SCH-302/702

Start Date: 2004-08-11

Sponsor Name: Janssen-Cilag, Johnson & Johnson spol. s.r.o.

Full Title: A Randomized, 6-Week Double-Blind, Placebo-Controlled Study With an Optional 24-Week Open-Label Extension to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliper...

Medical condition: Schizophrenia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2004-000798-71

Sponsor Protocol Number: 1

Start Date: 2004-08-11

Sponsor Name: Imperial College London

Full Title: Efficacy of Levetiracetam in Pendular Nystagmus: A Randomized, Double-blind, Placebo-controlled trial with crossover

Medical condition: Pendular Nystagmus from various etiology

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-000487-27

Sponsor Protocol Number: 0663-806

Start Date: 2004-08-10

Sponsor Name: Merck Sharp & Dohme (Sweden) AB

Full Title: A Double-Blind, Parallel-Group, 4-week Trial to Assess the Efficacy and Safety of Etoricoxib 60mg and Diclofenac 150mg in Patients with Chronic Low Back Pain

Medical condition: Chronic Low Back Pain

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10008837		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) HU (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-000414-39

Sponsor Protocol Number: BUP4203

Start Date: 2004-08-10

Sponsor Name: Mundipharma OY

Full Title: A randomised, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the long-term efficacy and safety of Norspan® versus placebo Norspan in subjects with chronic, moderate...

Medical condition: Chronic, moderate to severe osteoarthritis pain of the hip and/or knee.

Disease:	Version	SOC Term	Classification Code	Term	Level
	5.1		10031161		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) SE (Completed)

Trial results: View results

Últimos ensayos

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas